Showing results (151-160 of 190) with videos related to

Sort By:
Pageof 19
Cancer|May 7, 2014
A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: results of a Sarcoma Alliance for Research Through Collaboration studyAlberto S Pappo, Gilles Vassal, John J Crowley, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2023
Phase I/II Study of the WEE1 Inhibitor Adavosertib (AZD1775) in Combination with Carboplatin in Children with Advanced Malignancies: Arm C of the AcSé-ESMART TrialSusanne A Gatz, Anne C Harttrampf, Caroline Brard, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 16, 2022
Metastatic Rhabdomyosarcoma: Results of the European Paediatric Soft Tissue Sarcoma Study Group MTS 2008 Study and Pooled Analysis With the Concurrent BERNIE StudyReineke A Schoot, Julia C Chisholm, Michela Casanova, et al.
European Journal of Cancer (Oxford, England : 1990)|June 25, 2018
Phase I results of a phase I/II study of weekly nab-paclitaxel in paediatric patients with recurrent/refractory solid tumours: A collaboration with innovative therapies for children with cancerLucas Moreno, Michela Casanova, Julia C Chisholm, et al.
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|June 29, 2024
Mechanisms of sensitivity and resistance to CDK4/CDK6 inhibitors in hormone receptor-positive breast cancer treatmentAntonino Glaviano, Seth A Wander, Richard D Baird, et al.
European Journal of Cancer (Oxford, England : 1990)|June 4, 2016
Implementation of mechanism of action biology-driven early drug development for children with cancerAndrew D J Pearson, Ralf Herold, Raphaël Rousseau, et al.
Cancer Research|January 26, 2022
Immune Infiltrate and Tumor Microenvironment Transcriptional Programs Stratify Pediatric Osteosarcoma into Prognostic Groups at DiagnosisAntonin Marchais, Maria Eugenia Marques da Costa, Bastien Job, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2024
Chemo-immunotherapy with dinutuximab beta in patients with relapsed/progressive high-risk neuroblastoma: does chemotherapy backbone matter?Patricia Raiser, Gudrun Schleiermacher, Marion Gambart, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 5, 2014
A five-gene hedgehog signature developed as a patient preselection tool for hedgehog inhibitor therapy in medulloblastomaYaping Shou, Douglas M Robinson, Dereck D Amakye, et al.
The American Journal of Surgical Pathology|May 5, 2021
Infantile Rhabdomyosarcomas With VGLL2 Rearrangement Are Not Always an Indolent Disease: A Study of 4 Aggressive Cases With Clinical, Pathologic, Molecular, and Radiologic FindingsJoanna Cyrta, Arnaud Gauthier, Marie Karanian, et al.
Pageof 19